Navigation Links
New Primer Co-Authored by Novation Describes Potential Impact of Biosimilars on Pharmacy Practice; Opportunity for Hospitals to Manage Drug Expenditures
Date:11/20/2013

IRVING, Texas, Nov. 20, 2013 /PRNewswire/ -- Health systems professionals should prepare now for the introduction of biosimilars, a new category of pharmaceuticals intended to offer lower cost alternatives for some of the most expensive medications purchased by health care organizations.  This insight comes from newly published research co-authored by Novation, the leading health care supply chain expertise, analytics and contracting company.

The primer, "Biosimilars: Implications for health-system pharmacists," appears in the Nov. 15 issue of the American Journal of Health-System Pharmacy (AJHP).  The peer-reviewed article provides an update on the scientific, regulatory, and clinical practice considerations that are continuing to shape the developing market of biosimilars in the United States. Unlike generic small molecules, biosimilars represent a greater level of complexity in design, manufacturing, and potential for immunogenicity.  As a result, they will require more robust clinical evaluation prior to formulary adoption.  Health care practitioners, particularly pharmacists, must take action now to enable their organizations to realize the full extent of value offered by these products.

According to lead author Steven Lucio, PharmD, BCPS, senior director, Clinical Solutions and Pharmacy Program Development, Novation, "While the development of biosimilars has been slow, we are rapidly approaching a point in time where these products no longer reside in only theoretical terms. Health-system pharmacists must recognize the unique molecular and manufacturing characteristics that differentiate small molecules from biologics and prepare to entertain clinical safety and efficacy discussions of biosimilars. Fortunately, we have the European e
'/>"/>

SOURCE Novation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. PrimeraDx Announces Commencement of Product Development Collaboration with Eli Lilly and Company
2. L.S.E. (Barcelona) anuncia la primera financiación del antiplaquetario NmC por inversores españoles y suizos
3. El Reino Unido, primer país europeo en ejecutar el programa Zostavax
4. PrimerLife.com, a Skolkovo Participant Company, Celebrates Anniversary of DNA Discovery with Launch of New Social Network
5. PrimerLife.com celebra el aniversario del descubrimiento del ADN con una nueva red social
6. Tras el exitoso lanzamiento en Estados Unidos, el nuevo Simbionix U/S Mentor se introducirá por primera vez en Europa
7. Ziehm Imaging: Primer brazo C motorizado para su uso en ORs híbridos
8. CryoLife anuncia el primer implante europeo del injerto HeRO
9. Aratana Therapeutics to Host Pet Therapeutics Primer and Product Update Event
10. Austen BioInnovation Institute in Akron Attracts Nationally Known Speakers For Conference on Value-driven Engineering, April 23-24
11. Netsmarts Focus on Innovation to Help Health and Human Service Providers Span the Spectrum of Care in the Healthcare 3.0 Environment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... 2014  Edwards Lifesciences Corporation (NYSE: EW ... valves and hemodynamic monitoring, announced today that it will ... a strong launch of Edwards Lifesciences Foundation,s new charitable ... the global communities where its employees live and work. ... will exceed $8 million, including more than $7 million ...
(Date:11/21/2014)... /CNW Telbec/ - KLOX Technologies Inc. ("KLOX" or the ... Todd Martensen has been hired ... of Chief Commercial Officer, to oversee KLOX,s commercial launch ... for the treatment of chronic and other hard-to-heal wounds, ... in Europe . Mr. Martensen, a ...
(Date:11/21/2014)... GABLES, Fla. , Nov. 20, 2014   ... to become the first U.S. commercial producer of Molybdenum-99 ... a contract with INVAP to design its ... Fla. Mo-99 is the parent isotope of ... medicine procedures worldwide. In 2012, Congress passed legislation making ...
Breaking Medicine Technology:Edwards Lifesciences Increases Charitable Giving In 2014 To Support Launch Of Every Heartbeat Matters 2KLOX Technologies announces executive appointments 2KLOX Technologies announces executive appointments 3KLOX Technologies announces executive appointments 4Coqui RadioPharmaceuticals Inks Deal With INVAP 2
... , LAIYANG, China, Nov. 16 /PRNewswire-Asia-FirstCall/ ... "Company"),a U.S. pharmaceutical company with its principal operations in the ... a conference,call at 9:00 a.m. Eastern Time on Wednesday, November ... fiscal year 2010. , Conference Call ...
... , STAMFORD, Conn., Nov. 13 ... will be releasing a free trial version of its Zargis ... conference, taking place this November 15-17 in Orlando. Zargis is ... the companion hardware -- the 3M Littmann Electronic Stethoscope Model ...
Cached Medicine Technology:Jiangbo Pharmaceuticals, Inc. Announces Conference Call to Discuss Results for the First Quarter of Fiscal Year 2010 2Zargis to Release Trial Version of Cardioscan while Exhibiting with 3M(TM) Littmann(R) at American Heart Association Conference 2Zargis to Release Trial Version of Cardioscan while Exhibiting with 3M(TM) Littmann(R) at American Heart Association Conference 3
(Date:11/21/2014)... November 21, 2014 Body Well Therapy, a ... it accepts Spafinder massage gift cards and ... hotel massage in all service areas including throughout Florida and ... to go to the spa at all to redeem your ... of Body Well. "We may not be able to transport ...
(Date:11/21/2014)... The cost of diabetes care in the United States ... more than $322 billion annually, a new report shows. ... prediabetes care, which have risen 74 percent, and undiagnosed ... In 2012, excess medical costs and lost productivity ... American. That total includes $244 billion in medical costs ...
(Date:11/21/2014)... they,ve mapped the genome -- the genetic "blueprint" -- of ... it might help others with this very rare infection. ... , the tapeworm was removed from the brain of a ... so rare worldwide and completely unexpected in this country that ... pulled out from the brain," study lead author Hayley Bennett, ...
(Date:11/21/2014)... 21, 2014 MLF Biotech, Inc. has ... . Liv-Pro® Probiotics for Pets helps maintain digestive health ... a pet's intestinal flora after it experiences a period ... Liv-Pro Probiotics for Pets is a proprietary blend of ... seven live active bacteria strains that are safe and ...
(Date:11/21/2014)... 21, 2014 Saint Luke’s Mid ... The Guidelines®–Heart Failure Gold-Plus Quality Achievement Award for ... American Heart Association/American College of Cardiology Foundation in ... , Get With The Guidelines–Heart Failure is a ... the most up-to-date, research-based guidelines with the goal ...
Breaking Medicine News(10 mins):Health News:Body Well Mobile Massage Announces Acceptance of Spafinder Gift Cards for In Home Massage, Hotel Massage for Travelers 2Health News:Cost of Diabetes Care Keeps Climbing, Report Shows 2Health News:Ick! Tapeworm Infecting Man's Brain Yields Genetic Secrets 2Health News:MLF Biotech Introduces Liv-Pro Probiotics for Pets 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 3Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 4
... March 7 Alexza,Pharmaceuticals, Inc. (Nasdaq: ALXA ... webcast live during the Cowen & Company 28th ... 8:00 a.m. Eastern Time., The presentation will ... access the live presentation via the Web, please ...
... Affiliated Computer Services,Inc. (NYSE: ACS ) today ... to provide electronic health records and pharmacy,benefits management solutions. ... years,and a total value of $57 million if all ... will provide the state with several components,of ACS, electronic ...
... March 6 Nfocus Neuromedical, Inc.,announced today that ... StarFire Medical is a manufacturer of therapeutic implantable ... The assets acquired include products such as ... Silicone Balloon), also,known as the Endeavor Balloon Catheter, ...
... Webcast Scheduled for March 7, 2008 at 2:00 pm ... Ensign,Group, Inc. (Nasdaq: ENSG ), the parent company ... and assisted living,companies, today reported results for the fourth ... (Logo: http://www.newscom.com/cgi-bin/prnh/20071213/LATH168LOGO ), Highlights ...
... 6 QED International Associates, Inc.,administrator for the ... the HealthShares(TM) Exchange-Traded Funds, today announced,that effective at ... ISIS,Pharmaceuticals (Nasdaq: ISIS ) will replace Pharmion ... Index. Synta Pharmaceuticals Corp.,(Nasdaq: SNTA ) will ...
... A new study suggests that a type of acute ... one small molecule result in the over-activity of genes important ... myeloid leukemia (AML) and a gene mutation called NPM1, an ... The findings suggest new therapeutic targets for treating the disease ...
Cached Medicine News:Health News:Alexza's Corporate Presentation to be Webcast at the Cowen & Company 28th Annual Health Care Conference 2Health News:ACS Announces $57 Million Contract With Missouri HealthNet 2Health News:ACS Announces $57 Million Contract With Missouri HealthNet 3Health News:Nfocus Neuromedical Announces Acquisition of StarFire Medical 2Health News:The Ensign Group, Inc. Reports Fourth Quarter 2007 Earnings 2Health News:The Ensign Group, Inc. Reports Fourth Quarter 2007 Earnings 3Health News:The Ensign Group, Inc. Reports Fourth Quarter 2007 Earnings 4Health News:The Ensign Group, Inc. Reports Fourth Quarter 2007 Earnings 5Health News:The Ensign Group, Inc. Reports Fourth Quarter 2007 Earnings 6Health News:The Ensign Group, Inc. Reports Fourth Quarter 2007 Earnings 7Health News:The Ensign Group, Inc. Reports Fourth Quarter 2007 Earnings 8Health News:QED International Associates Announces Changes to the HealthShares(TM) Composite and HealthShares(TM) Cancer Indexes 2Health News:Low micro-RNA level linked to high gene activity in AML 2
... important diagnostic tool ... of a patient's ... important when deciding ... for patients receiving ...
The Karl Storz Videoscope offers maximum image quality and can be used in combination with standard documentation units. In contrast with conventional flexible endoscopes, images are displayed with ...
Maximum brightness, durability, universal power suply, microprocessor-controlled light output and, in the event of lamp failure or degredation, automatic switchover to an integraged spare lamp....
Integrated electronics, single-chip CCD camera with PAL and NTSC output. PAL output at 460 lines, NTSC output at 470 lines. 30mm focal length. 90mm length x 20mm diameter....
Medicine Products: